Publications by authors named "Cuiju Tang"

Claim this Profile
P
Plasma Thioredoxin Reductase as a Potential Diagnostic Biomarker for Breast Cancer.
Yixuan Hu, Yinxing Zhu, Junfeng Shi, Xiaowei Wei, Cuiju Tang

Clin Breast Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trop2-targeted therapy in breast cancer.
Yixuan Hu, Yinxing Zhu, Dan Qi, Cuiju Tang, Wenwen Zhang

Biomark Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of common genetic variants in family genes associated with gastric cancer survival in a Chinese population.
Yuetong Chen, Chen Li, Yi Shi, Jiali Dai, Yixuan Meng, Cuiju Tang

J Biomed Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thioredoxin reductase as a novel biomarker for the diagnosis and efficacy prediction of gastrointestinal malignancy: a large-scale, retrospective study.
Yixuan Hu, Yinxing Zhu, Weiwei Nie, Junfeng Shi, Xiaowei Wei, Cuiju Tang

Int J Clin Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer.
Yinxing Zhu, Yixuan Hu, Junfeng Shi, Xiaowei Wei, Yaqi Song, Cuiju Tang

Technol Cancer Res Treat· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disitamab vedotin, a novel HER2-directed antibody-drug conjugate in gastric cancer and other solid tumors.
Yixuan Hu, Yinxing Zhu, Xiaowei Wei, Cuiju Tang, Wenwen Zhang

Drugs Today (Barc)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The drugs screened by OncoVee-Mini-PDX have significantly benefited the patient with HER2-positive advanced gastric cancer.
Xuedan Zhu, Yinxing Zhu, Nan Chen, Cuiju Tang, Junfeng Shi

J Oncol Pharm Pract· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma thioredoxin reductase: a potential diagnostic biomarker for gastric cancer.
Yinxing Zhu, Yixuan Hu, Xuedan Zhu, Juan Zhang, Daolu Yuwen, Cuiju Tang

Carcinogenesis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knockdown of nuclear receptor binding SET domain-containing protein 1 (NSD1) inhibits proliferation and facilitates apoptosis in paclitaxel-resistant breast cancer cells via inactivating the Wnt/β-catenin signaling pathway.
Yi Chen, Xiao Li, Jin Xu, Hua Xiao, Cuiju Tang

Bioengineered· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platinum-based systematic therapy in triple-negative breast cancer.
Yinxing Zhu, Yixuan Hu, Cuiju Tang, Xiaoxiang Guan, Wenwen Zhang

Biochim Biophys Acta Rev Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OncoVee™-MiniPDX-Guided Anticancer Treatment for Gastric Cancer Patients With Synchronous Liver Metastases: A Retrospective Cohort Analysis.
Yutong Ge, Xin Zhang, Wei Liang, Cuiju Tang, Dongying Gu

Front Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress and challenges of immunotherapy in triple-negative breast cancer.
Yinxing Zhu, Xuedan Zhu, Cuiju Tang, Xiaoxiang Guan, Wenwen Zhang

Biochim Biophys Acta Rev Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11.
Yi Chen, Weiwei Tang, Xuedan Zhu, Lele Zhang, Yinxing Zhu, Cuiju Tang

Bioengineered· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2-targeted therapies in gastric cancer.
Yinxing Zhu, Xuedan Zhu, Xiaowei Wei, Cuiju Tang, Wenwen Zhang

Biochim Biophys Acta Rev Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apatinib inhibits the proliferation of gastric cancer cells via the AKT/GSK signaling pathway .
Yi Chen, Nan Chen, Jin Xu, Xindong Wang, Xiaowei Wei, Cuiju Tang

Aging (Albany NY)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The regulatory relationship and function of LncRNA FAM225A-miR-206-ADAM12 in gastric cancer.
Nan Chen, Xuedan Zhu, Yinxing Zhu, Junfeng Shi, Juan Zhang, Cuiju Tang

Am J Transl Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor cells: A surrogate to predict the effect of treatment and overall survival in gastric adenocarcinoma.
Yinxing Zhu, Nan Chen, Manman Chen, Xiaowen Cui, Han Yang, Cuiju Tang

Int J Biol Markers· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: A case report.
Jiali Dai, Yuetong Chen, Cuiju Tang, Xiaowei Wei, Yang Gong

Medicine (Baltimore)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genetic variant located in the miR-532-5p-binding site of TGFBR1 is associated with the colorectal cancer risk.
Dongying Gu, Shuwei Li, Mulong Du, Cuiju Tang, Haiyan Chu

J Gastroenterol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isobavachalcone sensitizes cells to E2-induced paclitaxel resistance by down-regulating CD44 expression in ER+ breast cancer cells.
Junfeng Shi, Yi Chen, Wenxing Chen, Cuiju Tang, Honghong Zhang

J Cell Mol Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
Jin-Fei Chen, Peng Wu, Rui Xia, Jian Yang, Xin-Ying Huo, Cui-Ju Tang

Mol Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Benefit and Safety of Bevacizumab in Combination with Erlotinib as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: A Meta-Analysis.
Wei Xu, Yang Gong, Meng Kuang, Peng Wu, Chunxiang Cao, Cuiju Tang

Clin Drug Investig· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival benefit and safety of the combinations of FOLFOXIRI ± bevacizumab versus the combinations of FOLFIRI ± bevacizumab as first-line treatment for unresectable metastatic colorectal cancer: a meta-analysis.
Wei Xu, Meng Kuang, Yang Gong, Chunxiang Cao, Jinfei Chen, Cuiju Tang

Onco Targets Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common genetic variation in ETV6 is associated with colorectal cancer susceptibility.
Meilin Wang, Dongying Gu, Mulong Du, Zhi Xu, Suzhan Zhang, Cuiju Tang

Nat Commun· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.
Chunxiang Cao, Meng Kuang, Wei Xu, Xunlei Zhang, Jinfei Chen, Cuiju Tang

Jpn J Clin Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis